Labcorp Holdings INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Labcorp Holdings Inc. reported a 7.2% revenue increase to $13.95 billion in 2025, driven by organic growth and strategic acquisitions, while navigating healthcare cost pressures and investing in specialty testing and AI.
NYSE
Labcorp's 2024 annual report reveals a 7% revenue increase, fueled by strong performance in its core diagnostics and biopharma laboratory services.
NYSE
Labcorp's 2023 annual report details a 2.5% revenue increase, driven by strategic acquisitions and base business growth, alongside a focus on innovation and strategic partnerships.